Gp 1mg Tablet

Recommended starting dose is 1 or 2 mg once daily. Increase in 1 or 2 mg increments no more frequently than every 1-2 weeks based on glycemic response. Maximum recommended dose is 8 mg once daily.

Directions from the U.S. FDA-approved label for Glimepiride — your doctor or pharmacist may advise differently.

Glimepiride is contraindicated in patients with a history of a hypersensitivity reaction to: Glimepiride or any of the product's ingredients. Sulfonamide derivatives: Patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to Glimepiride. Do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. Reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g.

Excerpt from the U.S. FDA-approved label for Glimepiride. Talk to a pharmacist or doctor before use.

Hypoglycemia: May be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications. Hypersensitivity Reactions: Post-marketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue glimepiride, assess for other causes, institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes. Hemolytic Anemia: Can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non-sulfonylurea alternative..

Warnings and precautions excerpt from the U.S. FDA-approved label for Glimepiride — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are discussed in more detail below and elsewhere in the labeling: Hypoglycemia Hemolytic anemia In clinical trials, the most common adverse reactions with glimepiride were hypoglycemia, dizziness, asthenia, headache, and nausea. Common adverse reactions in clinical trials (≥5% and more common than with placebo) include hypoglycemia, headache, nausea, and dizziness.

Excerpt from the U.S. FDA-approved label for Glimepiride — not a complete list. Talk to a pharmacist or doctor about side effects.

98 brands · 36 makers in the NepalDoc catalog — see the full Glimepiride guide →

Store at 20º to 25ºC (68º to 77ºF) (See USP Controlled Room Temperature) Dispense in well-closed containers with safety closures.

Storage information from the U.S. FDA-approved label for Glimepiride.